THE Therapeutic Goods Administration has completed more than 750 complaint cases since the introduction of major reforms to regulations around advertising introduced just over six months ago.
In Jul 2018 the TGA assumed responsibility for handling all complaints about therapeutic goods advertising, with the new arrangements providing a simpler and more consistent system for both advertisers and consumers.
A new risk-based complaints handling approach has allowed the TGA to focus efforts on issues that pose the greatest risks to public health and safety, with complaints categorised into one of four risk levels: low, medium, high & critical - based on the health and safety risk associated with the advertisement, as well as the compliance history of the advertiser.
All advertising complaint outcomes are now published on a searchable portal, and new enforcement powers have seen action against Gumby Gumby Australia, Peptide Clinics Australia and Evolution Supplements.
The above article was sent to subscribers in Pharmacy Daily's issue from 29 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Jan 19